These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30547156)

  • 21. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.
    Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM
    J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing treatment for smoldering myeloma: is earlier better?
    Hernández JÁ; Martínez-López J; Lahuerta JJ
    Expert Rev Hematol; 2019 May; 12(5):345-354. PubMed ID: 30907176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
    Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
    Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
    Schmiedeskamp M; Harpe S; Polk R; Oinonen M; Pakyz A
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1070-6. PubMed ID: 19803724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoldering multiple myeloma: Reviewing the rationale for intervention.
    Gertz M
    Leuk Lymphoma; 2022 Sep; 63(9):2033-2040. PubMed ID: 35532298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of Diagnostic Codes to Identify Carbon Monoxide Poisoning in Taiwan's Claims Data.
    Chiang MY; Shao SC; Liao SC
    Front Pharmacol; 2022; 13():882632. PubMed ID: 35784736
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive Predictive Value of
    Ivey LC; Rodriguez FH; Shi H; Chong C; Chen J; Raskind-Hood CL; Downing KF; Farr SL; Book WM
    J Am Heart Assoc; 2023 Aug; 12(16):e030821. PubMed ID: 37548168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the Rate of Revision Discectomies After Primary Discectomy on a National Scale?
    Virk SS; Diwan A; Phillips FM; Sandhu H; Khan SN
    Clin Orthop Relat Res; 2017 Nov; 475(11):2752-2762. PubMed ID: 28849429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoldering, asymptomatic stage 1, and indolent myeloma.
    Greipp PR
    Curr Treat Options Oncol; 2000 Jun; 1(2):119-26. PubMed ID: 12057049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Outcomes After TKA: Do All Databases Produce Similar Findings?
    Bedard NA; Pugely AJ; McHugh M; Lux N; Otero JE; Bozic KJ; Gao Y; Callaghan JJ
    Clin Orthop Relat Res; 2018 Jan; 476(1):52-63. PubMed ID: 29529616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes.
    Kern EF; Maney M; Miller DR; Tseng CL; Tiwari A; Rajan M; Aron D; Pogach L
    Health Serv Res; 2006 Apr; 41(2):564-80. PubMed ID: 16584465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database.
    Goldberg DS; Lewis JD; Halpern SD; Weiner MG; Lo Re V
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):103-7. PubMed ID: 23124932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma.
    Lonial S; Jacobus S; Fonseca R; Weiss M; Kumar S; Orlowski RZ; Kaufman JL; Yacoub AM; Buadi FK; O'Brien T; Matous JV; Anderson DM; Emmons RV; Mahindra A; Wagner LI; Dhodapkar MV; Rajkumar SV
    J Clin Oncol; 2020 Apr; 38(11):1126-1137. PubMed ID: 31652094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
    Prescott JD; Factor S; Pill M; Levi GW
    J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes.
    Chomistek AK; Phiri K; Doherty MC; Calderbank JF; Chiuve SE; McIlroy BH; Snabes MC; Enger C; Seeger JD
    Drug Saf; 2023 Feb; 46(2):209-222. PubMed ID: 36656445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data.
    Ammann EM; Kalsekar I; Yoo A; Johnston SS
    Pharmacoepidemiol Drug Saf; 2018 Oct; 27(10):1092-1100. PubMed ID: 30003617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health outcomes coding trends in the US Food and Drug Administration's Sentinel System during transition to International Classification of Diseases-10 coding system: A brief review.
    Nam YH; Mendelsohn AB; Panozzo CA; Maro JC; Brown JS
    Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):838-842. PubMed ID: 33638243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?
    Matarraz S; Paiva B; Diez-Campelo M; López-Corral L; Pérez E; Mateos MV; Giraldo P; Hernández MT; San Miguel JF; Orfao A;
    Haematologica; 2012 Oct; 97(10):1608-11. PubMed ID: 22511492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.